Bolt Biotherapeutics (BOLT) Leases (2019 - 2025)
Historic Leases for Bolt Biotherapeutics (BOLT) over the last 7 years, with Q3 2025 value amounting to $19.9 million.
- Bolt Biotherapeutics' Leases rose 1865.0% to $19.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.9 million, marking a year-over-year increase of 1865.0%. This contributed to the annual value of $21.8 million for FY2024, which is 1378.66% up from last year.
- As of Q3 2025, Bolt Biotherapeutics' Leases stood at $19.9 million, which was up 1865.0% from $20.5 million recorded in Q2 2025.
- Over the past 5 years, Bolt Biotherapeutics' Leases peaked at $26.0 million during Q2 2021, and registered a low of $11.5 million during Q1 2021.
- In the last 5 years, Bolt Biotherapeutics' Leases had a median value of $21.1 million in 2025 and averaged $20.8 million.
- As far as peak fluctuations go, Bolt Biotherapeutics' Leases skyrocketed by 10277.05% in 2022, and later crashed by 1570.58% in 2024.
- Over the past 5 years, Bolt Biotherapeutics' Leases (Quarter) stood at $24.4 million in 2021, then fell by 9.71% to $22.1 million in 2022, then dropped by 13.37% to $19.1 million in 2023, then increased by 13.79% to $21.8 million in 2024, then decreased by 8.62% to $19.9 million in 2025.
- Its Leases was $19.9 million in Q3 2025, compared to $20.5 million in Q2 2025 and $21.1 million in Q1 2025.